
2023 was a landmark year for biology. From unearthing the genetic secrets of creatures that roamed the Earth a million years ago to mapping the hidden architecture of the human body, researchers pushed the boundaries of what we know about life itself.
Quanta Magazine, in its year-end review, highlighted several discoveries that are set to reshape textbooks and open new frontiers in medicine and evolution. Here is a breakdown of the biggest finds.
For decades, the oldest DNA ever sequenced came from specimens no older than a few hundred thousand years. That changed in 2023. Scientists successfully extracted and analysed genetic material from a mammoth tooth that is over one million years old, found frozen in Siberian permafrost.
This feat shattered the previous record by nearly half a million years. The DNA revealed a previously unknown lineage of mammoths that predates the well-known woolly mammoth. It also showed how these giants adapted to cold climates over deep time, providing a direct window into evolution that fossils alone cannot offer.
Human anatomy textbooks may need a reprint. Researchers identified a previously overlooked network of fluid-filled spaces in connective tissues across the body. Dubbed the interstitium, this structure may act as a shock absorber and a highway for immune cells. Some scientists argue it qualifies as a new organ.
In a separate breakthrough, biologists described a mechanism for a sixth sense — the ability to sense mechanical forces on the skin beyond touch and pain. Specialised cells called Merkel cells were found to form a direct electrical link with nerve endings, enabling the skin to detect subtle textures and pressure. The work could lead to better prosthetics that mimic natural sensation.
Artificial intelligence continued its march through biology. The AlphaFold AI system, developed by DeepMind, had already predicted the 3D shapes of all 200 million known proteins. In 2023, the team released a database covering nearly all catalogued proteins from every species on Earth.
The implications are vast. Understanding protein shape is key to designing drugs and enzymes. With this tool, researchers can now predict how a protein will fold in minutes instead of years. A separate AI model called ESMFold used language-based learning to predict structures even for proteins that have no known relatives, opening the door to discovering entirely new biological functions.
After years of hope and hype, CRISPR gene editing delivered its first approved therapy. In late 2023, regulators in the UK and the US greenlit a treatment for sickle cell disease and beta-thalassemia. The therapy, called Casgevy, uses CRISPR to edit a patient's own stem cells, reactivating fetal haemoglobin to compensate for the defective adult version.
Early trial results showed that most patients were freed from painful vaso-occlusive crises. This marks a turning point: gene editing has moved from the lab bench to the bedside. More therapies for conditions like inherited blindness and certain cancers are now racing through clinical trials.
The pace of discovery shows no sign of slowing. In 2024, expect further refinements in AI-driven drug design, more ancient genomes from warmer climates, and the rollout of CRISPR therapies to larger patient populations. The question is no longer if biology can deliver breakthroughs — it is how fast we can translate them into real-world solutions.